1Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth controls and carcinogenesis[ J]. J Cell Physiol, 2001,183( 1 ) :1-9.
2Furlanetto RW, Harwell SE, Frick KK. Insulin-like growth factor-1 induce cyclin-D1 expression in MG-63 human osteosarcoma cells in vitro [J]. Mol Endocrinal, 1994, 8(4) :510-517.
3Jaques G, Rotsch M, Wegmaun C, et al. Production of immunoreactive insulin-like growth factor 1 and response to exogenous IGF-Ⅰ in small cell lung cancer cell line[J]. Exp Cell Res, 1988, 176(2) :336-343.
4Li BD, Khosravi MJ, Berkel HJ, et al. Free insulin-like growth factor 1 and breast cancer risk[J]. Int J Cancer, 2001,91(5) :736-739.
5Hochscheid R, Jaques G, Wegmann B. Transfection of human insulin-like growth factor-binding protein-3 gene inhibits cell growth and tu- morigenicity: a cell culture model for lung cancer [ J ]. J Endocfinol, 2000,166(3) :553-563.
6Butt AJ, Firth SM, King MA, et al. Insulin-like growth factor binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53- independent radiation-induced apoptesis in human breast cancer cells [ J]. J Biol Chem, 2000,275(50) :39174-39181.
7Devi GR, Sprenger CO, Plymate SR, et al. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo[J]. Prostate, 2002,51 (2) : 141-152.
8MacDonald RG, Schaffer BS, Kang U, et al. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3 [ J ]. J Gastroenterol Hepatol, 1999, 14(1):72-78.
9Pavelic J, Pavelic L, Karadza J, et ah Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma [ J ]. Mol Med, 2002,8(3) :149-157.
